Mark Your Calendar...
According to the American Cancer Society, nearly
219,440
Americans will learn they have lung cancer – the most common type of thoracic cancer – this year. More Americans die each year from lung cancer than from breast, prostate and colorectal cancers combined (www.lungcancer.org).
Surgery, chemotherapy and radiation therapy are typically used as treatments. This multidisciplinary meeting will promote interaction between these disciplines to achieve the best possible outcome for thoracic cancer patients. This model will also bring together physician specialists from around the world for interdisciplinary discussions on the latest research and state-of-the-art care for thoracic cancers.
Attend and learn to:
- Report current standards of care in thoracic cancers.
- Identify current novel therapies and agents currently under investigation in thoracic malignancies.
- Describe and discuss the role of multimodality therapy in thoracic cancers.
- Investigate the latest advances in the management of thoracic cancers.
- Explore supportive outcomes.
Registration and Housing are Open! Register now and save up to $100!
The early-bird registration rate is available until September 8. Register now.
Don’t forget to book your housing! A block of rooms has been set aside for symposium attendees at a discounted rate until November 11, 2010. Reserve your room online now.
Call for Abstracts:
The deadline to submit an abstract was July 14, 2010, 11:59 p.m.; the submission site it now closed. Abstract notifications will be sent out in early September. For more information please contact Cristin Watson.
Late-breaking Abstracts:
The late-breaking abstract submission site opens on Wednesday, September 8 and closes on Wednesday, October 6, 2010, at 11:59 p.m.
Learn more about late-breaking abstracts and how to submit.